1 | http://www.cancer.gov/cancertopics/druginfo/methotrexate |
2 | http://www.cancer.gov/cancertopics/druginfo/nanoparticlepaclitaxel |
3 | http://www.cancer.gov/cancertopics/druginfo/doxorubicinhydrochloride |
4 | http://www.cancer.gov/cancertopics/druginfo/fluorouracil |
5 | http://www.cancer.gov/cancertopics/druginfo/imiquimod |
6 | http://www.cancer.gov/cancertopics/druginfo/aldesleukin |
7 | http://www.cancer.gov/cancertopics/druginfo/alemtuzumab |
8 | http://www.cancer.gov/cancertopics/druginfo/pemetrexeddisodium |
9 | http://www.cancer.gov/cancertopics/druginfo/aminolevulinicacid |
10 | http://www.cancer.gov/cancertopics/druginfo/anastrozole |
11 | http://www.cancer.gov/cancertopics/druginfo/aprepitant |
12 | http://www.cancer.gov/cancertopics/druginfo/exemestane |
13 | http://www.cancer.gov/cancertopics/druginfo/nelarabine |
14 | http://www.cancer.gov/cancertopics/druginfo/arsenictrioxide |
15 | http://www.cancer.gov/cancertopics/druginfo/bevacizumab |
16 | http://www.cancer.gov/cancertopics/druginfo/azacitidine |
17 | http://www.cancer.gov/cancertopics/druginfo/bendamustinehydrochloride |
18 | http://www.cancer.gov/cancertopics/druginfo/bexarotene |
19 | http://www.cancer.gov/cancertopics/druginfo/tositumomab-I131tositumomab |
20 | http://www.cancer.gov/cancertopics/druginfo/bortezomib |
21 | http://www.cancer.gov/cancertopics/druginfo/IrinotecanHydrochloride |
22 | http://www.cancer.gov/cancertopics/druginfo/capecitabine |
23 | http://www.cancer.gov/cancertopics/druginfo/carboplatin |
24 | http://www.cancer.gov/cancertopics/druginfo/cetuximab |
25 | http://www.cancer.gov/cancertopics/druginfo/cisplatin |
26 | http://www.cancer.gov/cancertopics/druginfo/cyclophosphamide |
27 | http://www.cancer.gov/cancertopics/druginfo/clofarabine |
28 | http://www.cancer.gov/cancertopics/druginfo/cytarabine |
29 | http://www.cancer.gov/cancertopics/druginfo/decitabine |
30 | http://www.cancer.gov/cancertopics/druginfo/dasatinib |
31 | http://www.cancer.gov/cancertopics/druginfo/fda-degarelix |
32 | http://www.cancer.gov/cancertopics/druginfo/liposomalcytarabine |
33 | http://www.cancer.gov/cancertopics/druginfo/dexrazoxanehydrochloride |
34 | http://www.cancer.gov/cancertopics/druginfo/docetaxel |
35 | http://www.cancer.gov/cancertopics/druginfo/doxorubicin-hydrochloride-liposome |
36 | http://www.cancer.gov/cancertopics/druginfo/leuprolideacetate |
37 | http://www.cancer.gov/cancertopics/druginfo/epirubicinhydrochloride |
38 | http://www.cancer.gov/cancertopics/druginfo/oxaliplatin |
39 | http://www.cancer.gov/cancertopics/druginfo/eltrombopagolamine |
40 | http://www.cancer.gov/cancertopics/druginfo/erlotinibhydrochloride |
41 | http://www.cancer.gov/cancertopics/druginfo/etoposidephosphate |
42 | http://www.cancer.gov/cancertopics/druginfo/etoposide |
43 | http://www.cancer.gov/cancertopics/druginfo/raloxifenehydrochloride |
44 | http://www.cancer.gov/cancertopics/druginfo/fulvestrant |
45 | http://www.cancer.gov/cancertopics/druginfo/letrozole |
46 | http://www.cancer.gov/cancertopics/druginfo/methotrexate |
47 | http://www.cancer.gov/cancertopics/druginfo/fludarabinephosphate |
48 | http://www.cancer.gov/cancertopics/druginfo/fludarabinephosphate |
49 | http://www.cancer.gov/cancertopics/druginfo/gefitinib |
50 | http://www.cancer.gov/cancertopics/druginfo/gemcitabinehydrochloride |
51 | http://www.cancer.gov/cancertopics/druginfo/gemtuzumabozogamicin |
52 | http://www.cancer.gov/cancertopics/druginfo/imatinibmesylate |
53 | http://www.cancer.gov/cancertopics/druginfo/trastuzumab |
54 | http://www.cancer.gov/cancertopics/druginfo/topotecanhydrochloride |
55 | http://www.cancer.gov/cancertopics/druginfo/ibritumomabtiuxetan |
56 | http://www.cancer.gov/cancertopics/druginfo/ixabepilone |
57 | http://www.cancer.gov/cancertopics/druginfo/palifermin |
58 | http://www.cancer.gov/cancertopics/druginfo/lapatinibditosylate |
59 | http://www.cancer.gov/cancertopics/druginfo/lenalidomide |
60 | http://www.cancer.gov/cancertopics/druginfo/leucovorincalcium |
61 | http://www.cancer.gov/cancertopics/druginfo/temozolomide |
62 | http://www.cancer.gov/cancertopics/druginfo/fda-plerixafor |
63 | http://www.cancer.gov/cancertopics/druginfo/sorafenibtosylate |
64 | http://www.cancer.gov/cancertopics/druginfo/nilotinib |
65 | http://www.cancer.gov/cancertopics/druginfo/tamoxifencitrate |
66 | http://www.cancer.gov/cancertopics/druginfo/romiplostim |
67 | http://www.cancer.gov/cancertopics/druginfo/pegaspargase |
68 | http://www.cancer.gov/cancertopics/druginfo/paclitaxel |
69 | http://www.cancer.gov/cancertopics/druginfo/panitumumab |
70 | http://www.cancer.gov/cancertopics/druginfo/fda-plerixafor |
71 | http://www.cancer.gov/cancertopics/druginfo/rituximab |
72 | http://www.cancer.gov/cancertopics/druginfo/romiplostim |
73 | http://www.cancer.gov/cancertopics/druginfo/talc |
74 | http://www.cancer.gov/cancertopics/druginfo/sunitinibmalate |
75 | http://www.cancer.gov/cancertopics/druginfo/thalidomide |
76 | http://www.cancer.gov/cancertopics/druginfo/temsirolimus |
77 | http://www.cancer.gov/cancertopics/druginfo/dexrazoxanehydrochloride |
78 | http://www.cancer.gov/cancertopics/druginfo/vorinostat |
79 | http://www.cancer.gov/cancertopics/druginfo/vincristinesulfate |
80 | http://www.cancer.gov/cancertopics/druginfo/leucovorincalcium |
81 | http://www.cancer.gov/cancertopics/druginfo/zoledronicacid |
82 | http://www.cancer.gov/cancertopics/druginfo/zoledronicacid |